Boston Scientific Corporation vs Kimberly Clark Corp — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Kimberly Clark Corp trades at $108.57 (market cap $36.11B). The key difference: Boston Scientific Corporation is far larger — about 2.1× Kimberly Clark Corp's market cap, and Kimberly Clark Corp pays a 4.72% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | KMB | |
|---|---|---|
Market Cap | $74.19B | $36.11B |
Sector | Health | Consumer Staples |
52-Week High | $108.14 | $134.81 |
52-Week Low | $42.63 | $93.05 |
Enterprise Value | $86.27B | $41.67B |
Dividend Yield | — | 4.72% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →